Anti-SARS-CoV-2 Monoclonal Antibody IGM-6268

**Semantic type:** Amino Acid, Peptide, or Protein|Immunologic Factor|Pharmacologic Substance

**Definition:** An engineered human immunoglobulin M (IgM) monoclonal antibody directed against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), that can potentially be used for the treatment and prevention of COVID-19. Upon intranasal administration, anti-SARS-CoV-2 IgM monoclonal antibody IGM-6268 targets and binds to SARS-CoV-2, neutralizing SARS-CoV-2. This may slow the progression of the disease and accelerate recovery, and may potentially provide temporary protection against infection with SARS-CoV-2.

**Synonyms:** - IGM 6268 - IGM-6268 - IGM6268